OverviewSuggest Edit

Perrigo Company plc, a top five global over-the-counter (OTC) consumer goods and pharmaceutical company, offers consumers and customers high quality products at affordable prices. From its beginnings in 1887 as a packager of generic home remedies, Perrigo, headquartered in Ireland, has grown to become the world's largest manufacturer of OTC products and supplier of infant formulas for the store brand market. The Company is also a leading provider of branded OTC products, generic extended topical prescription products and receives royalties from Multiple Sclerosis drug Tysabri®. Perrigo provides “Quality Affordable Healthcare Products®” across a wide variety of product categories and geographies primarily in North America, Europe, and Australia, as well as other key markets including Israel and China.

TypePublic
Founded1887
HQDublin, IE
Websiteperrigo.com
Employee Ratings3.5

Latest Updates

Employees (est.) (Dec 2018)10,600(+2%)
Job Openings159
Revenue (FY, 2016)$1.3 B(-67%)
Share Price (Jun 2019)$43.8

Key People/Management at Perrigo

Uwe Roehrhoff

Uwe Roehrhoff

CEO
Ron Winowiecki

Ron Winowiecki

CFO
Svend Andersen

Svend Andersen

Executive Vice President and President, Consumer Healthcare International
Tom Farrington

Tom Farrington

Executive Vice President and Chief Information Officer
Ron Janish

Ron Janish

Executive Vice President of Global Operations and Supply Chain
Todd W. Kingma

Todd W. Kingma

Executive Vice President, General Counsel and Secretary
Show more

Perrigo Office Locations

Perrigo has offices in Dublin and Allegan
Dublin, IE (HQ)
2 Lower Grand Canal St
Allegan, US
515 Eastern Ave
Show all (2)

Perrigo Financials and Metrics

Perrigo Revenue

Perrigo's revenue was reported to be $1.33 b in FY, 2016 which is a 71.1% decrease from the previous period.
USD

Net income (FY, 2018)

131.0m

Market capitalization (10-Jun-2019)

6.0b

Closing stock price (10-Jun-2019)

43.8
Perrigo's current market capitalization is $6 b.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2018

Revenue

4.1b1.3b

Revenue growth, %

13%(71%)

Sales and marketing expense

319.0m

Operating expense total

319.0m1.6b
Quarterly
USDQ1, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Revenue

1.3b1.4b1.5b1.4b1.2b

Cost of goods sold

795.9m860.3m913.8m848.6m729.6m

Gross profit

548.8m522.9m567.2m506.3m464.4m

Gross profit Margin, %

41%38%38%37%39%
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2018

Cash

799.5m785.6m622.3m

Accounts Receivable

935.1m1.3b

Inventories

631.6m838.9m795.0m878.0m

Current Assets

2.6b3.2b2.8b
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q4, 2017

Cash

135.03.6b588.9m641.8m362.7m3.1b

Accounts Receivable

924.7m

Inventories

641.8m637.0m888.0m868.8m894.6m884.6m800.2m

Current Assets

4.7m2.3b2.6b5.4b5.1b3.0b3.0b2.6b5.1b
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2018

Net Income

128.0m131.0m

Depreciation and Amortization

457.0m

Inventories

83.0m

Cash From Operating Activities

593.0m
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Net Income

96.3m70.2m(94.9m)(334.6m)(140.3m)(1.4b)71.6m

Depreciation and Amortization

182.5m369.3m556.3m109.4m

Inventories

(57.0m)(14.8m)(50.3m)(29.9m)500.0k

Accounts Payable

(194.0m)300.0k(41.1m)(51.8m)2.5m
Show all financial metrics

Perrigo Online and Social Media Presence

Embed Graph

Perrigo News and Updates

Perrigo To Present At Upcoming Investor Conferences

DUBLIN, Aug. 22, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), today announced that CEO and President, Murray S. Kessler and CFO, Ray Silcock, will host one-on-one meetings at the Barclay's Global Consumer Staples Conference on September 5, 2019 in Boston. Mr. Kessler will...

Perrigo Announces Patent Litigation Settlement for the Generic Version of Nascobal® Nasal Spray

DUBLIN, Aug. 21, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced that it has settled its Hatch-Waxman litigation relating to Nascobal® (Cyanocobalamin) Nasal Spray brought by Endo Pharmaceuticals Inc. Terms of the settlement are confidential. Annual market...

Perrigo Announces Resignation Of Jeffrey C. Smith From Its Board Of Directors

DUBLIN, Aug. 7, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading provider of "Quality Affordable Self-Care Products™", today announced that Jeffrey C. Smith, Managing Member, Chief Executive Officer, and Chief Investment Officer of Starboard Value LP, who has been a...

PetIQ, Inc. Completes Acquisition of Perrigo Animal Health

Announces Appointment of Pet and Consumer Packaged Goods Industry Veteran, Michael Smith, as Executive Vice President, Products Division Announces Appointment of Pet and Consumer Packaged Goods Industry Veteran, Michael Smith, as Executive Vice President, Products Division

Perrigo shares up 1.5% after FDA approves marketing application for generic antibacterial

Shares of Dublin-based Perrigo Co. Plc rose 1.5% in premarket trade Wednesday after the company said the U.S. Food and Drug Administration had approved a development partner's marketing application for a generic version of Metrogel-Vaginal, a treatment for bacterial vaginosis. The generic was devel…

Perrigo shares up 2% after company boosts adjusted full-year EPS guidance by 10 cents

Shares of Perrigo Co. Plc rose 2% in premarket trade Tuesday after the company raised its adjusted full-year EPS guidance to between $3.75 and $4.05 from between $3.65 and $3.95. The Dublin-based pharmaceutical company said the 10-cent boost came from its $750 million cash acquisition of oral-care …
Show more

Perrigo Blogs

Perrigo Charitable Foundation Donates More Than $20,000 to Hurricane Dorian Relief Efforts

Perrigo Charitable Foundation Donates More Than $20,000 to Hurricane Dorian Relief Efforts sarah Mon, 09/16/2019 - 14:27 DUBLIN, Ireland and Allegan, Michigan – September 13, 2019 – The Perrigo Charitable Foundation and Perrigo employees have joined together to help victims of Hurrican…

Perrigo Advances Consumer Self-Care Growth Strategy with Acquisition of Prevacid®24HR

Perrigo Advances Consumer Self-Care Growth Strategy with Acquisition of Prevacid®24HR sarah Thu, 09/05/2019 - 13:26 FOR IMMEDIATE RELEASE   PERRIGO ADVANCES CONSUMER SELF-CARE GROWTH STRATEGY WITH ACQUISITION OF PREVACID®24HR   Expands U.S. OTC market and gastrointestinal categor…

Perrigo Advances Consumer Self-Care Growth Strategy With Acquisition Of Prevacid®24hr

- Expands U.S. OTC market and gastrointestinal category leadership positions

Perrigo Donates $50,000 to the Saugatuck Center for the Arts to Support an Entire Year of Arts Education Programming

Perrigo Donates $50,000 to the Saugatuck Center for the Arts to Support an Entire Year of Arts Education Programming sarah Mon, 07/15/2019 - 19:01 DUBLIN, Ireland and Allegan, Michigan – July 15, 2019 --The Perrigo Company Charitable Foundation is proud to announce a donation of $50,0…
Show more

Perrigo Frequently Asked Questions

  • When was Perrigo founded?

    Perrigo was founded in 1887.

  • Who are Perrigo key executives?

    Perrigo's key executives are Uwe Roehrhoff, Ron Winowiecki and Svend Andersen.

  • How many employees does Perrigo have?

    Perrigo has 10,600 employees.

  • Who are Perrigo competitors?

    Competitors of Perrigo include Bausch Health Companies, Horizon Pharma and Cytokinetics.

  • Where is Perrigo headquarters?

    Perrigo headquarters is located at 2 Lower Grand Canal St, Dublin.

  • Where are Perrigo offices?

    Perrigo has offices in Dublin and Allegan.

  • How many offices does Perrigo have?

    Perrigo has 2 offices.